Clinical Trial Update: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ONC206 for newly diagnosed and recurrent diffuse midline gliomas and other recurrent malignant CNS tumors; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Diffuse Midline Glioma
• Ependymoma
• Glioblastoma
• Malignant Central Nervous System Neoplasm
• Spinal Cord Glioma
• Who Grade Iii Glioma

Drugs mentioned

• ONC206 (ONC206)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Diffuse Midline Glioma (DMG), Glioblastoma | Phase 1 | Status: RECRUITING